⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL386016 | 0.84 | — | — | |
| SCHEMBL29458226 | 0.80 | — | — | |
| SCHEMBL1356834 | 0.80 | — | — | |
| SCHEMBL29002574 | 0.80 | — | — | |
| SCHEMBL11182374 | 0.80 | — | — | |
| SCHEMBL31359195 | 0.80 | — | — | |
| SCHEMBL263539 | 0.80 | — | — | |
| SCHEMBL324444 | 0.80 | — | — | |
| SCHEMBL30031882 | 0.80 | — | — | |
| SCHEMBL2046791 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 423 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116064877-B | Kit and method for rapidly detecting enterobacter cloacae by utilizing LAMP technology | 宁夏大学 | 2024-09-20 | — | — | CN | claimed |
| CN-114891862-B | LAMP and Multi-LAMP-based reagent set for rapidly detecting cell species and cross contamination | 武汉大学 | 2023-12-12 | — | — | CN | claimed |
| CN-115340447-B | One-pot synthesis of two caged macrocyclic aromatic hydrocarbons and separation and purification method thereof | 天津科技大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116064877-A | Kit and method for rapidly detecting enterobacter cloacae by utilizing LAMP technology | 宁夏大学 | 2023-05-05 | — | — | CN | claimed |
| CN-114409054-B | Water treatment method for removing organic pollutants by activating persulfate and cooperatively controlling halogenated byproducts | 北京林业大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115340447-A | One-pot synthesis method of two caged macrocyclic arenes and separation and purification method thereof | 天津科技大学 | 2022-11-15 | — | — | CN | claimed |
| CN-114891862-A | LAMP and Multi-LAMP-based reagent group for rapidly detecting cell species and cross contamination | 武汉大学 | 2022-08-12 | — | — | CN | claimed |
| CN-114409054-A | Water treatment method for removing organic pollutants by activating persulfate and cooperatively controlling halogenated byproducts | 北京林业大学 | 2022-04-29 | — | — | CN | claimed |
| CN-113528687-A | Primer group, detection method, kit and application for rapidly detecting staphylococcus aureus by LAMP technology | 武汉海关技术中心 | 2021-10-22 | — | — | CN | claimed |
| CN-111455080-A | Method for rapidly detecting pathogenic vibrios of invertebrate | 青岛大螠海创生物科技有限公司 | 2020-07-28 | — | — | CN | claimed |
| CN-106495999-B | A kind of aromatic aldehyde and its synthetic method | 亳州学院 | 2019-08-16 | — | — | CN | claimed |
| CN-109994732-A | The application of phenols lithium salt compound, lithium ion secondary battery and preparation method thereof | 上海电气国轩新能源科技有限公司 | 2019-07-09 | — | — | CN | claimed |
| CN-108003317-A | A kind of silicone elastomer and its preparation method and application | 四川大学 | 2018-05-08 | — | — | CN | claimed |
| CN-106495999-A | A kind of aromatic aldehyde and its synthetic method | 亳州学院 | 2017-03-15 | — | — | CN | claimed |
| CN-104672450-A | Poly dimethyl silicate bromohydroquinone ester polymer and preparation method thereof | SUZHOU YANGQIAO CHEMICAL TECHNOLOGY CO LTD | 2015-06-03 | — | — | CN | claimed |
| EP-0746540-A1 | PREPARATION OF 4,6-DIAMINORESORCINOL THROUGH A BISAZOARYLRESORCINOL INTERMEDIATE | THE DOW CHEMICAL COMPANY (US) | 1996-12-11 | — | — | EP | claimed |
| US-5453542-A | Preparation of 4,6-diaminoresorcinol through a bisazoarylresorcinol intermediate | THE DOW CHEMICAL COMPANY (US) | 1995-09-26 | — | — | US | claimed |
| WO-1995023130-A1 | PREPARATION OF 4,6-DIAMINORESORCINOL THROUGH A BISAZOARYLRESORCINOL INTERMEDIATE | THE DOW CHEMICAL COMPANY (US) | 1995-08-31 | — | — | WO | claimed |
| US-4487975-A | Etherification of phenols | RHONE-POULENC INDUSTRIES (FR) | 1984-12-11 | — | — | US | claimed |
| EP-4733299-A1 | SULFUR-CONTAINING FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Braegen Pharmaceutical Co., Ltd. (CN) | 2026-04-29 | — | — | EP | disclosed |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12527790-B2 | Checkpoint kinase 1 (CHK1) inhibitors and uses thereof | BOUNDLESS BIO, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-12492180-B2 | Process and intermediates for the preparation of Voxelotor | CURIA SPAIN, S.A.U. (ES) | 2025-12-09 | — | — | US | disclosed |
| US-20250326771-A1 | PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY | VIIV HEALTHCARE CO (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250304564-A1 | NOVEL KV3 MODULATORS | AUTIFONY THERAPEUTICS LTD (GB) | 2025-10-02 | — | — | US | disclosed |
| US-12358901-B2 | KV3 modulators | AUTIFONY THERAPEUTICS LIMITED (GB) | 2025-07-15 | — | — | US | disclosed |
| US-20250032471-A1 | Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS INC (US) | 2025-01-30 | — | — | US | disclosed |
| CN-115066424-B | Kv3 modulators | 奥蒂福尼疗法有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024240186-A1 | SULFUR-CONTAINING FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳博芮健制药有限公司 | 2024-11-28 | — | — | WO | disclosed |
| US-20240383830-A1 | NOVEL CANNABIDIOL DERIVATIVE, METHOD FOR PREPARING SAME, AND COMPOSITION FOR COGNITIVE FUNCTION IMPROVEMENT COMPRISING SAME | KANGWON UNIVERSITY-INDUSTRY COOPERATION FOUNDATION (KR) | 2024-11-21 | — | — | US | disclosed |
| US-12146037-B2 | Composition of phthalonitrile resin matrix for polymer composite materials, method for fabrication thereof, method for manufacturing of polymer composite material, and material obtained by this method | Joint Stock Company “Institute of New Carbon Materials and Technologies” (RU) | 2024-11-19 | — | — | US | disclosed |
| CN-113316568-B | 2-Formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin | 全球血液疗法股份有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118834974-A | LAMP visual detection primer group, kit and detection method for jujube witches broom phytoplasma | 北京市农林科学院 | 2024-10-25 | — | — | CN | disclosed |
| US-20240329525-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING CURED RELIEF PATTERN, AND SEMICONDUCTOR APPARATUS | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-116064877-B | Kit and method for rapidly detecting enterobacter cloacae by utilizing LAMP technology | 宁夏大学 | 2024-09-20 | — | — | CN | disclosed |
| EP-4406934-A1 | NOVEL CANNABIDIOL DERIVATIVE, METHOD FOR PREPARING SAME, AND COMPOSITION FOR COGNITIVE FUNCTION IMPROVEMENT COMPRISING SAME | Kangwon University-Industry Cooperation Foundation (KR) | 2024-07-31 | — | — | EP | disclosed |
| EP-3867247-B1 | NOVEL COMPOUNDS | AUTIFONY THERAPEUTICS LTD (GB) | 2024-07-24 | — | — | EP | disclosed |
| EP-3102208-B2 | CRYSTALLINE POLYMORPH OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-3877447-B1 | COMPOSITION OF PHTHALONITRILE RESIN MATRIX FOR POLYMER COMPOSITE MATERIALS, METHOD FOR FABRICATION THEREOF, METHOD FOR MANUFACTURING OF POLYMER COMPOSITE MATERIAL, AND MATERIAL OBTAINED BY THIS METHOD | JOINT STOCK COMPANY (RU) | 2024-07-17 | — | — | EP | disclosed |
| US-12023393-B2 | Polymerizable 4,4′-spirobi[chromane]-2,2′-diones and curable compositions including the same | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240210827-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING CURED RELIEF PATTERN, AND SEMICONDUCTOR APPARATUS | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240208990-A1 | SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-06-27 | — | — | US | disclosed |
| EP-4389755-A1 | FLUORESCENT COMPOUND AND FLUORESCENCE-LABELED BIOSUBSTANCE OBTAINED USING SAME | FUJIFILM Corporation (JP) | 2024-06-26 | — | — | EP | disclosed |
| CN-113365992-B | Process and intermediates for the preparation of Wo Sailuo torr | 晶体制药独资有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240122815-A1 | POLYMERIZABLE 4,4'-SPIROBI[CHROMANE]-2,2'-DIONES AND CURABLE COMPOSITIONS INCLUDING THE SAME | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-04-18 | — | — | US | disclosed |
| EP-4347602-A1 | SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME | Solventum Intellectual Properties Company (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4347582-A1 | CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF | Boundless Bio, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20240110918-A1 | FLUORESCENT COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | FUJIFILM CORPORATION (JP) | 2024-04-04 | — | — | US | disclosed |
| CN-117715905-A | Checkpoint kinase 1 (CHK 1) inhibitors and uses thereof | 无界生物公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-4308571-A1 | POLYMERIZABLE 4,4'-SPIROBI[CHROMANE]-2,2'-DIONES AND CURABLE COMPOSITIONS INCLUDING THE SAME | 3M Innovative Properties Company (US) | 2024-01-24 | — | — | EP | disclosed |
| CN-117286222-A | Chromogenic reagent for LAMP (loop-mediated isothermal amplification), amplification system and detection kit | 上海思路迪生物医学科技有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-114891862-B | LAMP and Multi-LAMP-based reagent set for rapidly detecting cell species and cross contamination | 武汉大学 | 2023-12-12 | — | — | CN | disclosed |
| CN-115340447-B | One-pot synthesis of two caged macrocyclic aromatic hydrocarbons and separation and purification method thereof | 天津科技大学 | 2023-10-20 | — | — | CN | disclosed |
| EP-3860975-B1 | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-3860975-B1 | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2023-10-18 | — | — | EP | disclosed |
| US-20230310423-A1 | CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF | BOUNDLESS BIO, INC. | 2023-10-05 | — | — | US | disclosed |
| US-20230310423-A1 | CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF | BOUNDLESS BIO, INC. | 2023-10-05 | — | — | US | disclosed |
| US-20230310423-A1 | CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF | BOUNDLESS BIO, INC. | 2023-10-05 | — | — | US | disclosed |
| CN-110770211-B | Alpha, beta unsaturated amide compound | 协和麒麟株式会社 | 2023-09-19 | — | — | CN | disclosed |
| US-11707462-B2 | Checkpoint kinase 1 (CHK1) inhibitors and uses thereof | BOUNDLESS BIO, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11707462-B2 | Checkpoint kinase 1 (CHK1) inhibitors and uses thereof | BOUNDLESS BIO, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11707462-B2 | Checkpoint kinase 1 (CHK1) inhibitors and uses thereof | BOUNDLESS BIO, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| EP-3848363-B1 | TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND | MEDSHINE DISCOVERY INC (CN) | 2023-07-19 | — | — | EP | disclosed |
| CN-110294703-B | Composition for organic photoelectric device, organic photoelectric device and display device | 三星SDI株式会社 | 2023-07-11 | — | — | CN | disclosed |
| CN-113820920-B | Photosensitive resin composition, method for producing cured relief pattern, and semiconductor device | 旭化成株式会社 | 2023-07-04 | — | — | CN | disclosed |
| US-20230159507-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230159507-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230159507-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-116143738-A | Anthracene asymmetric dibenzoheterocyclic compound and application thereof | 烟台显华科技集团股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116143737-A | Compound with anthracene-linked asymmetric dibenzoheterocycle and application thereof | 烟台显华科技集团股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116064877-A | Kit and method for rapidly detecting enterobacter cloacae by utilizing LAMP technology | 宁夏大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-114409054-B | Water treatment method for removing organic pollutants by activating persulfate and cooperatively controlling halogenated byproducts | 北京林业大学 | 2023-04-07 | — | — | CN | disclosed |
| WO-2023043197-A1 | NOVEL CANNABIDIOL DERIVATIVE, METHOD FOR PREPARING SAME, AND COMPOSITION FOR COGNITIVE FUNCTION IMPROVEMENT COMPRISING SAME | 강원대학교 산학협력단 | 2023-03-23 | — | — | WO | disclosed |
| US-11583527-B2 | Hydantoin derivatives useful as Kv3 inhibitors | AUTIFONY THERAPEUTICS LIMITED (GB) | 2023-02-21 | — | — | US | disclosed |
| US-20230026313-A1 | CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF | BOUNDLESS BIO, INC. | 2023-01-26 | — | — | US | disclosed |
| US-11548880-B2 | Modulators of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-11541052-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2023-01-03 | — | — | US | disclosed |
| CN-110088680-B | Double-layer photosensitive layer roll | 旭化成株式会社 | 2022-12-30 | — | — | CN | disclosed |
| CN-108430972-B | Alpha, beta-unsaturated amide compound | 协和麒麟株式会社 | 2022-12-27 | — | — | CN | disclosed |
| US-20220395492-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2022-12-15 | — | — | US | disclosed |
| US-20220395492-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2022-12-15 | — | — | US | disclosed |
| EP-4100402-A1 | KV3 MODULATORS | Autifony Therapeutics Limited (GB) | 2022-12-14 | — | — | EP | disclosed |
| WO-2022251502-A1 | CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF | BOUNDLESS BIO, INC. (US) | 2022-12-01 | — | — | WO | disclosed |
| WO-2022248947-A1 | SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-12-01 | — | — | WO | disclosed |
| CN-115340447-A | One-pot synthesis method of two caged macrocyclic arenes and separation and purification method thereof | 天津科技大学 | 2022-11-15 | — | — | CN | disclosed |
| CN-111349103-B | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2022-11-08 | — | — | CN | disclosed |
| CN-111499646-B | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2022-11-04 | — | — | CN | disclosed |
| CN-112028902-B | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2022-10-28 | — | — | CN | disclosed |
| CN-115185157-A | Photosensitive resin composition, method for producing cured relief pattern, and semiconductor device | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| CN-113402814-B | PP (polypropylene) backing plate for slicing single/polycrystalline silicon rods and preparation method thereof | 江阴市嘉宇新材料有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-11452720-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2022-09-27 | — | — | US | disclosed |
| WO-2022195364-A1 | POLYMERIZABLE 4,4'-SPIROBI[CHROMANE]-2,2'-DIONES AND CURABLE COMPOSITIONS INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-09-22 | — | — | WO | disclosed |
| US-11447471-B2 | α,β-unsaturated amide compound | KYOWA KIRIN CO., LTD. (JP) | 2022-09-20 | — | — | US | disclosed |
| CN-115066424-A | Kv3 modulators | 奥蒂福尼疗法有限公司 | 2022-09-16 | — | — | CN | disclosed |
| EP-4046988-A1 | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN | Global Blood Therapeutics, Inc. (US) | 2022-08-24 | — | — | EP | disclosed |
| EP-4046988-A1 | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN | Global Blood Therapeutics, Inc. (US) | 2022-08-24 | — | — | EP | disclosed |
| CN-114891862-A | LAMP and Multi-LAMP-based reagent group for rapidly detecting cell species and cross contamination | 武汉大学 | 2022-08-12 | — | — | CN | disclosed |
| EP-3390394-B1 | HYDANTOIN MODULATORS OF KV3 CHANNELS | AUTIFONY THERAPEUTICS LTD (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-3390394-B1 | HYDANTOIN MODULATORS OF KV3 CHANNELS | AUTIFONY THERAPEUTICS LTD (GB) | 2022-05-25 | — | — | EP | disclosed |
| US-11332455-B2 | α,β-unsaturated amide compound | KYOWA KIRIN CO., LTD. (JP) | 2022-05-17 | — | — | US | disclosed |
| CN-114409054-A | Water treatment method for removing organic pollutants by activating persulfate and cooperatively controlling halogenated byproducts | 北京林业大学 | 2022-04-29 | — | — | CN | disclosed |
| CN-114213390-A | Crystalline polymorph of a compound | 全球血液疗法股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114181195-A | Crystalline polymorph of a compound | 全球血液疗法股份有限公司 | 2022-03-15 | — | — | CN | disclosed |
| CN-114181194-A | Crystalline polymorph of a compound | 全球血液疗法股份有限公司 | 2022-03-15 | — | — | CN | disclosed |
| US-20220073493-A1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF VOXELOTOR | CURIA SPAIN, S.A.U. (ES) | 2022-03-10 | — | — | US | disclosed |
| US-20220056008-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF VOXELOTOR | CRYSTAL PHARMA, S.A.U. (ES) | 2022-02-24 | — | — | US | disclosed |
| US-20220054490-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2022-02-24 | — | — | US | disclosed |
| US-11234987-B2 | Isoxazole compounds as inhibitors of heat shock proteins | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2022-02-01 | — | — | US | disclosed |
| US-20220017712-A1 | Composition of Phthalonitrile Resin Matrix for Polymer Composite Materials, Method for Fabrication Thereof, Method for Manufacturing of Polymer Composite Material, and Material Obtained by this Method | JOINT STOCK COMPANY "INSTITUTE OF NEW CARBON MATERIALS AND TECHNOLOGIES" (RU) | 2022-01-20 | — | — | US | disclosed |
| EP-3880654-B1 | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2021-12-29 | — | — | EP | disclosed |
| EP-3880654-B1 | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2021-12-29 | — | — | EP | disclosed |
| US-11197859-B2 | Hydantoin derivatives useful as Kv3 inhibitors | AUTIFONY THERAPEUTICS LIMITED (GB) | 2021-12-14 | — | — | US | disclosed |
| US-20210380551-A1 | ALPHA,BETA-UNSATURATED AMIDE COMPOUND | KYOWA KIRIN CO., LTD. (JP) | 2021-12-09 | — | — | US | disclosed |
| CN-113528687-A | Primer group, detection method, kit and application for rapidly detecting staphylococcus aureus by LAMP technology | 武汉海关技术中心 | 2021-10-22 | — | — | CN | disclosed |
| CN-108250189-B | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2021-09-28 | — | — | CN | disclosed |
| EP-3880654-A1 | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN | Global Blood Therapeutics, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |
| CN-113402814-A | PP (polypropylene) backing plate for slicing single/polycrystalline silicon rod and preparation method thereof | 江阴市嘉宇新材料有限公司 | 2021-09-17 | — | — | CN | disclosed |
| EP-3877447-A1 | COMPOSITION OF PHTHALONITRILE RESIN MATRIX FOR POLYMER COMPOSITE MATERIALS, METHOD FOR FABRICATION THEREOF, METHOD FOR MANUFACTURING OF POLYMER COMPOSITE MATERIAL, AND MATERIAL OBTAINED BY THIS METHOD | Joint Stock Company (RU) | 2021-09-15 | — | — | EP | disclosed |
| US-20210276985-A1 | NOVEL COMPOUNDS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2021-09-09 | — | — | US | disclosed |
| CN-113316568-A | 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin | 全球血液疗法股份有限公司 | 2021-08-27 | — | — | CN | disclosed |
| WO-2021156584-A1 | KV3 MODULATORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2021-08-12 | — | — | WO | disclosed |
| EP-3860975-A1 | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE | Global Blood Therapeutics, Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| EP-3848363-A1 | TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND | Medshine Discovery Inc. (CN) | 2021-07-14 | — | — | EP | disclosed |
| CN-108137497-B | Bicyclic derivatives, process for their preparation and pharmaceutical compositions containing them | 法国施维雅药厂 | 2021-06-15 | — | — | CN | disclosed |
| US-20210161876-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2021-06-03 | — | — | US | disclosed |
| US-20210161876-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2021-06-03 | — | — | US | disclosed |
| US-20210155612-A1 | Alpha,Beta-UNSATURATED AMIDE COMPOUND | KYOWA KIRIN CO., LTD. (JP) | 2021-05-27 | — | — | US | disclosed |
| US-11014884-B2 | Modulators of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2021-05-25 | — | — | US | disclosed |
| EP-3793979-A1 | 1,3,5-TRIS(6-METHYLPYRIDIN-2-YLOXY)BENZENE DERIVATIVES AND RELATED COMPOUNDS AS NLRX1 LIGANDS FOR TREATING INFLAMMATORY DISEASES | LANDOS BIOPHARMA, INC. (US) | 2021-03-24 | — | — | EP | disclosed |
| US-10948822-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
| CN-107635970-B | Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators | 詹森药业有限公司 | 2021-03-12 | — | — | CN | disclosed |
| US-20210047309-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2021-02-18 | — | — | US | disclosed |
| US-20210023084-A1 | NOVEL COMPOUNDS | AUTIFONY SRL (IT) | 2021-01-28 | — | — | US | disclosed |
| EP-3300500-B9 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2021-01-13 | — | — | EP | disclosed |
| EP-3102208-B1 | CRYSTALLINE POLYMORPH OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2021-01-13 | — | — | EP | disclosed |
| CN-112028902-A | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2020-12-04 | — | — | CN | disclosed |
| US-20200377485-A1 | HYDANTOIN MODULATORS OF KV3 CHANNELS | AUTIFONY THERAPEUTICS LTD (GB) | 2020-12-03 | — | — | US | disclosed |
| US-20200360379-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2020-11-19 | — | — | US | disclosed |
| US-10835534-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2020-11-17 | — | — | US | disclosed |
| US-10787428-B2 | α,β-unsaturated amide compound | KYOWA KIRIN CO., LTD. (JP) | 2020-09-29 | — | — | US | disclosed |
| EP-3712129-A1 | ALPHA, BETA-UNSATURATED AMIDE COMPOUND | Kyowa Kirin Co., Ltd. (JP) | 2020-09-23 | — | — | EP | disclosed |
| CN-108137545-B | Triazole agonists of the APJ receptor | 美国安进公司 | 2020-09-22 | — | — | CN | disclosed |
| EP-3313817-B1 | BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SERVIER LAB (FR) | 2020-09-16 | — | — | EP | disclosed |
| EP-3452466-B1 | HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2020-08-12 | — | — | EP | disclosed |
| CN-111499646-A | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2020-08-07 | — | — | CN | disclosed |
| CN-111455080-A | Method for rapidly detecting pathogenic vibrios of invertebrate | 青岛大螠海创生物科技有限公司 | 2020-07-28 | — | — | CN | disclosed |
| US-10722502-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-07-28 | — | — | US | disclosed |
| US-10722502-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-07-28 | — | — | US | disclosed |
| CN-108264631-B | Curing agent and resin composition using the same | 协立化学产业株式会社 | 2020-07-14 | — | — | CN | disclosed |
| CN-111349103-A | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2020-06-30 | — | — | CN | disclosed |
| US-10683285-B2 | Modulators of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-06-16 | — | — | US | disclosed |
| US-20200179385-A1 | NOVEL COMPOUNDS | AUTIFONY SRL (IT) | 2020-06-11 | — | — | US | disclosed |
| US-20200157085-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-05-21 | — | — | US | disclosed |
| CN-106701961-B | Reverse transcription loop-mediated isothermal amplification primer, kit and detection method for visually detecting Hobi-like pestivirus | 南阳师范学院 | 2020-05-15 | — | — | CN | disclosed |
| US-20200140384-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-05-07 | — | — | US | disclosed |
| EP-3288936-B1 | BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-05-06 | — | — | EP | disclosed |
| WO-2020079422-A1 | NOVEL COMPOUNDS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2020-04-23 | — | — | WO | disclosed |
| US-10618909-B2 | Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2020-04-14 | — | — | US | disclosed |
| WO-2020072377-A1 | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-04-09 | — | — | WO | disclosed |
| WO-2020072377-A1 | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-04-09 | — | — | WO | disclosed |
| US-10611730-B2 | Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2020-04-07 | — | — | US | disclosed |
| EP-3300500-B1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2020-02-26 | — | — | EP | disclosed |
| US-10555945-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2020-02-11 | — | — | US | disclosed |
| CN-110770211-A | α unsaturated amide compound | 协和麒麟株式会社 | 2020-02-07 | — | — | CN | disclosed |
| CN-104428339-B | Curing agent and resin composition using the same | 协立化学产业株式会社 | 2020-01-07 | — | — | CN | disclosed |
| CN-110294703-A | Composition, organic electro-optic device and display device for organic electro-optic device | 三星SDI株式会社 | 2019-10-01 | — | — | CN | disclosed |
| US-10413550-B2 | Isoxazole compounds as inhibitors of heat shock proteins | THE INSTITUTE OF CANCER RESEARCH (GB) | 2019-09-17 | — | — | US | disclosed |
| US-20190255031-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2019-08-22 | — | — | US | disclosed |
| US-20190255031-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2019-08-22 | — | — | US | disclosed |
| CN-106495999-B | A kind of aromatic aldehyde and its synthetic method | 亳州学院 | 2019-08-16 | — | — | CN | disclosed |
| US-20190248805-A1 | BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2019-08-15 | — | — | US | disclosed |
| US-10344016-B2 | Bromotriazole intermediates | AMGEN INC. (US) | 2019-07-09 | — | — | US | disclosed |
| CN-109994732-A | The application of phenols lithium salt compound, lithium ion secondary battery and preparation method thereof | 上海电气国轩新能源科技有限公司 | 2019-07-09 | — | — | CN | disclosed |
| US-20190192516-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2019-06-27 | — | — | US | disclosed |
| EP-2793311-B1 | METAL COMPLEX DYE, PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE SOLUTION, AND COMPOUND | FUJIFILM CORP (JP) | 2019-06-19 | — | — | EP | disclosed |
| US-10323041-B2 | Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2019-06-18 | — | — | US | disclosed |
| US-10265316-B2 | Hydantoin derivatives useful as Kv3 inhibitors | AUTIFONY THERAPEUCTICS LIMITED (GB) | 2019-04-23 | — | — | US | disclosed |
| US-20190100510-A1 | BROMOTRIAZOLE INTERMEDIATES | AMGEN INC. (US) | 2019-04-04 | — | — | US | disclosed |
| US-20190092735-A1 | BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-03-28 | — | — | US | disclosed |
| EP-3452466-A1 | HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | Amgen Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| US-10221162-B2 | Triazole agonists of the APJ receptor | AMGEN INC. (US) | 2019-03-05 | — | — | US | disclosed |
| US-20190010176-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2019-01-10 | — | — | US | disclosed |
| US-20190010136-A1 | ALPHA,BETA-UNSATURATED AMIDE COMPOUND | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2019-01-10 | — | — | US | disclosed |
| US-20190000849-A1 | NOVEL COMPOUNDS | AUTIFONY THERAPEUTICS LIMITED | 2019-01-03 | — | — | US | disclosed |
| US-20180373148-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-12-27 | — | — | US | disclosed |
| US-10150760-B2 | Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor | AMGEN INC. (US) | 2018-12-11 | — | — | US | disclosed |
| EP-2970184-B1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2018-12-05 | — | — | EP | disclosed |
| US-10137118-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2018-11-27 | — | — | US | disclosed |
| EP-3401309-A1 | a, ß UNSATURATED AMIDE COMPOUND | Kyowa Hakko Kirin Co., Ltd. (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-20180319773-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2018-11-08 | — | — | US | disclosed |
| EP-3390394-A1 | HYDANTOIN MODULATORS OF KV3 CHANNELS | Autifony Therapeutics Limited (GB) | 2018-10-24 | — | — | EP | disclosed |
| US-10098881-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2018-10-16 | — | — | US | disclosed |
| US-20180289686-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2018-10-11 | — | — | US | disclosed |
| US-20180258098-A1 | BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2018-09-13 | — | — | US | disclosed |
| US-10058550-B2 | Methods of treating heart failure | AMGEN INC. (US) | 2018-08-28 | — | — | US | disclosed |
| US-20180222895-A1 | COMPOUNDS FOR USE IN PREPARING HETEROCYCLIC TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2018-08-09 | — | — | US | disclosed |
| US-10043980-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| EP-3075731-B1 | PHENANTHRO[4,5-BCA]FURAN COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2018-07-25 | — | — | EP | disclosed |
| CN-108250189-A | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2018-07-06 | — | — | CN | disclosed |
| US-9988369-B2 | Heterocyclic triazole compounds as agonists of the APJ receptor | AMGEN INC. (US) | 2018-06-05 | — | — | US | disclosed |
| US-9981887-B1 | Synthesis of phenylethynylbenzenes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2018-05-29 | — | — | US | disclosed |
| US-9981887-B1 | Synthesis of phenylethynylbenzenes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2018-05-29 | — | — | US | disclosed |
| CN-108003317-A | A kind of silicone elastomer and its preparation method and application | 四川大学 | 2018-05-08 | — | — | CN | disclosed |
| EP-3313817-A1 | NEW BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Les Laboratoires Servier (FR) | 2018-05-02 | — | — | EP | disclosed |
| EP-3300500-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | Amgen Inc. (US) | 2018-04-04 | — | — | EP | disclosed |
| EP-3288936-A1 | BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2018-03-07 | — | — | EP | disclosed |
| US-20180036308-A1 | NOVEL COMPOUNDS | AUTIFONY SRL (IT) | 2018-02-08 | — | — | US | disclosed |
| CN-107619412-A | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2018-01-23 | — | — | CN | disclosed |
| US-9868721-B2 | Triazole agonists of the APJ receptor | AMGEN INC. (US) | 2018-01-16 | — | — | US | disclosed |
| US-9845310-B2 | Intermediates for preparing triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-12-19 | — | — | US | disclosed |
| CN-105132556-B | Method and Primer composition of a kind of quick detection the pathogen of Botrytis cinerea to QoI series bactericidal agent resistances | 南京农业大学 | 2017-12-12 | — | — | CN | disclosed |
| US-9833452-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2017-12-05 | — | — | US | disclosed |
| US-20170326152-A1 | Isoxazole Compounds As Inhibitors Of Heat Shock Proteins | VERNALIS DEVELOPMENT LIMITED (GB) | 2017-11-16 | — | — | US | disclosed |
| WO-2017192485-A1 | HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| US-20170320860-A1 | HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-11-09 | — | — | US | disclosed |
| US-20170281625-A1 | METHODS OF TREATING HEART FAILURE | AMGEN INC. | 2017-10-05 | — | — | US | disclosed |
| US-20170273981-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2017-09-28 | — | — | US | disclosed |
| US-20170273981-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2017-09-28 | — | — | US | disclosed |
| US-20170273981-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2017-09-28 | — | — | US | disclosed |
| US-9751864-B2 | Methods for preparing triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-9745286-B2 | Triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-08-29 | — | — | US | disclosed |
| EP-2937344-B1 | PYRIDINYL- AND PYRAZINYL -METHYLOXY - ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) | GLAXO GROUP LTD (GB) | 2017-08-23 | — | — | EP | disclosed |
| EP-2970339-B1 | 1-HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS | LILLY CO ELI (US) | 2017-08-16 | — | — | EP | disclosed |
| US-9718793-B2 | Isoxazole compounds as inhibitors of heat shock proteins | VERNALIS (R&D) LTD. (GB) | 2017-08-01 | — | — | US | disclosed |
| WO-2017103604-A1 | HYDANTOIN MODULATORS OF KV3 CHANNELS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017103604-A1 | HYDANTOIN MODULATORS OF KV3 CHANNELS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2017-06-22 | — | — | WO | disclosed |
| CN-106701961-A | Reverse transcription loop-mediated isothermal amplification primer, kit and detection method for visually detecting Hobi-like pest virus | 南阳师范学院 | 2017-05-24 | — | — | CN | disclosed |
| US-9656997-B2 | Triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656998-B2 | Intermediates for preparing triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-9617285-B2 | 1-hydroxy-benzooxaboroles as antiparasitic agents | ELI LILLY AND COMPANY (US) | 2017-04-11 | — | — | US | disclosed |
| CN-106495999-A | A kind of aromatic aldehyde and its synthetic method | 亳州学院 | 2017-03-15 | — | — | CN | disclosed |
| US-9573936-B2 | Triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-20170042871-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-16 | — | — | US | disclosed |
| US-20170044131-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-16 | — | — | US | disclosed |
| US-20170042897-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-16 | — | — | US | disclosed |
| US-20170042872-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-16 | — | — | US | disclosed |
| US-20170037026-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-09 | — | — | US | disclosed |
| US-20170035744-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-09 | — | — | US | disclosed |
| US-9564274-B2 | Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and compound | FUJIFILM CORPORATION (JP) | 2017-02-07 | — | — | US | disclosed |
| US-9564274-B2 | Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and compound | FUJIFILM CORPORATION (JP) | 2017-02-07 | — | — | US | disclosed |
| WO-2016207217-A1 | NEW BICYCLIC DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2016-12-29 | — | — | WO | disclosed |
| EP-3102208-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | Global Blood Therapeutics, Inc. (US) | 2016-12-14 | — | — | EP | disclosed |
| US-20160355505-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2016-12-08 | — | — | US | disclosed |
| US-20160355505-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2016-12-08 | — | — | US | disclosed |
| US-20160346263-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-12-01 | — | — | US | disclosed |
| US-20160346263-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-12-01 | — | — | US | disclosed |
| US-20160346263-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-12-01 | — | — | US | disclosed |
| WO-2016187308-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2016-11-24 | — | — | WO | disclosed |
| US-20160340336-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2016-11-24 | — | — | US | disclosed |
| US-20160317537-A1 | NOVEL COMPOUNDS | AUTIFONY SRL (IT) | 2016-11-03 | — | — | US | disclosed |
| WO-2016176449-A1 | BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2016-11-03 | — | — | WO | disclosed |
| US-20160293847-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160293847-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| EP-3075731-A1 | PHENANTHRO[4,5-BCA]FURAN COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2016-10-05 | — | — | EP | disclosed |
| US-9447071-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| US-9447074-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2016-09-20 | — | — | US | disclosed |
| US-9447074-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2016-09-20 | — | — | US | disclosed |
| US-9447071-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| US-9447071-B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| US-20160251340-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2016-09-01 | — | — | US | disclosed |
| US-20160251340-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2016-09-01 | — | — | US | disclosed |
| US-20160251340-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | GLAXOSMITHKLINE S.P.A. (IT) | 2016-09-01 | — | — | US | disclosed |
| US-9422272-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2016-08-23 | — | — | US | disclosed |
| US-20160207904-A1 | CRYSTALLINE 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE ANSOLVATE SALTS | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-07-21 | — | — | US | disclosed |
| US-20160207904-A1 | CRYSTALLINE 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE ANSOLVATE SALTS | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-07-21 | — | — | US | disclosed |
| US-20160207904-A1 | CRYSTALLINE 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE ANSOLVATE SALTS | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-07-21 | — | — | US | disclosed |
| US-9346790-B2 | Hydantoin derivatives useful as Kv3 inhibitors | AUTIFONY THERAPEUTICS LIMITED (GB) | 2016-05-24 | — | — | US | disclosed |
| US-9346790-B2 | Hydantoin derivatives useful as Kv3 inhibitors | AUTIFONY THERAPEUTICS LIMITED (GB) | 2016-05-24 | — | — | US | disclosed |
| US-9346790-B2 | Hydantoin derivatives useful as Kv3 inhibitors | AUTIFONY THERAPEUTICS LIMITED (GB) | 2016-05-24 | — | — | US | disclosed |
| CN-103087650-B | For the composition of anisotropic conductive adhesive film, anisotropic conductive adhesive film and semiconductor device | Daiichi Woolen Co.,Ltd. (KR) | 2016-03-16 | — | — | CN | disclosed |
| EP-2788339-B1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LTD (GB) | 2016-03-09 | — | — | EP | disclosed |
| US-20160024127-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-01-28 | — | — | US | disclosed |
| US-20160024127-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-01-28 | — | — | US | disclosed |
| US-20160024127-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-01-28 | — | — | US | disclosed |
| EP-2970339-A1 | 1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS | Eli Lilly and Company (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20150353581-A1 | 1-HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS | ELI LILLY AND COMPANY (US) | 2015-12-10 | — | — | US | disclosed |
| US-20150336936-A1 | NOVEL COMPOUNDS | AUTIFONY SRL (IT) | 2015-11-26 | — | — | US | disclosed |
| EP-2937344-A1 | PYRIDINYL- AND PYRAZINYL -METHYLOXY - ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) | Glaxo Group Limited (GB) | 2015-10-28 | — | — | EP | disclosed |
| EP-2649066-B1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LTD (GB) | 2015-10-21 | — | — | EP | disclosed |
| EP-2649066-B1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LTD (GB) | 2015-10-21 | — | — | EP | disclosed |
| US-9133175-B2 | Compounds | AUTIFONY THERAPEUTICS LIMITED (GB) | 2015-09-15 | — | — | US | disclosed |
| US-20150225366-A1 | Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2015-08-13 | — | — | US | disclosed |
| US-20150225366-A1 | Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2015-08-13 | — | — | US | disclosed |
| US-20150225366-A1 | Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2015-08-13 | — | — | US | disclosed |
| WO-2015120133-A1 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2015-08-13 | — | — | WO | disclosed |
| US-20150166508-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2015-06-18 | — | — | US | disclosed |
| US-20150166508-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2015-06-18 | — | — | US | disclosed |
| WO-2015079251-A1 | QUINAZOLINE COMPOUNDS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2015-06-04 | — | — | WO | disclosed |
| CN-104672450-A | Poly dimethyl silicate bromohydroquinone ester polymer and preparation method thereof | SUZHOU YANGQIAO CHEMICAL TECHNOLOGY CO LTD | 2015-06-03 | — | — | CN | disclosed |
| US-8993560-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2015-03-31 | — | — | US | disclosed |
| US-8993560-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2015-03-31 | — | — | US | disclosed |
| US-20150057251-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-02-26 | — | — | US | disclosed |
| US-20150057251-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-02-26 | — | — | US | disclosed |
| US-20150057251-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-02-26 | — | — | US | disclosed |
| EP-2826821-A1 | METAL COMPLEX DYE, PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE ADSORPTION LIQUID COMPOSITION FOR DYE-SENSITIZED SOLAR CELL, SEMICONDUCTOR ELECTRODE FOR DYE-SENSITIZED SOLAR CELL, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL | Fujifilm Corporation (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-20140323508-A1 | NOVEL COMPOUNDS | AUTIFONY SRL (IT) | 2014-10-30 | — | — | US | disclosed |
| EP-2788339-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | Autifony Therapeutics Limited (GB) | 2014-10-15 | — | — | EP | disclosed |
| US-20140290746-A1 | METAL COMPLEX DYE, PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE SOLUTION, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140290746-A1 | METAL COMPLEX DYE, PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE SOLUTION, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| WO-2014149793-A1 | 1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS | ELI LILLY AND COMPANY (US) | 2014-09-25 | — | — | WO | disclosed |
| CN-101506267-B | Weather-resistant and heat-stable polymers with improved flow components | SABIC INNOVATIVE PLASTICS IP | 2014-08-27 | — | — | CN | disclosed |
| US-20130289026-A1 | Isoxazole Compounds As Inhibitors Of Heat Shock Proteins | VERNALIS DEVELOPMENT LIMITED (GB) | 2013-10-31 | — | — | US | disclosed |
| EP-2649066-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | Autifony Therapeutics Limited (GB) | 2013-10-16 | — | — | EP | disclosed |
| US-20130267510-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2013-10-10 | — | — | US | disclosed |
| US-20130267510-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2013-10-10 | — | — | US | disclosed |
| US-20130267510-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2013-10-10 | — | — | US | disclosed |
| CN-103328467-A | Hydantoin derivatives useful as KV3 inhibitors | AUTIFONY THERAPEUTICS LTD | 2013-09-25 | — | — | CN | disclosed |
| US-8507480-B2 | Isoxazole compounds as inhibitors of heat shock proteins | VERNALIS (R&D) LIMITED (GB) | 2013-08-13 | — | — | US | disclosed |
| WO-2013083994-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2013-06-13 | — | — | WO | disclosed |
| US-8450310-B2 | Isoxazole compounds as inhibitors of heat shock proteins | VERNALIS (R&D) LIMITED (GB) | 2013-05-28 | — | — | US | disclosed |
| CN-103087650-A | Composition for anisotropic conductive adhesive film, anisotropic conductive adhesive film and semiconductor device | CHEIL IND INC | 2013-05-08 | — | — | CN | disclosed |
| EP-2526941-A1 | Anti-inflammatory Modalities | Marshall Edwards, Inc. (US) | 2012-11-28 | — | — | EP | disclosed |
| EP-2526941-A1 | Anti-inflammatory Modalities | Marshall Edwards, Inc. (US) | 2012-11-28 | — | — | EP | disclosed |
| EP-2513092-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2012-10-24 | — | — | EP | disclosed |
| US-20120252797-A1 | Isoxazole Compounds As Inhibitors Of Heat Shock Proteins | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2012-10-04 | — | — | US | disclosed |
| US-20120232061-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2012-09-13 | — | — | US | disclosed |
| US-20120232061-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2012-09-13 | — | — | US | disclosed |
| EP-1611112-B1 | ISOXAZOLE COMPOUNDS AS INHIBITORS OF HEAT SHOCK PROTEINS | VERNALIS CAMBRIDGE LTD (GB) | 2012-08-22 | — | — | EP | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| WO-2012076877-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2012-06-14 | — | — | WO | disclosed |
| WO-2012076877-A1 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2012-06-14 | — | — | WO | disclosed |
| US-8178547-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-05-15 | — | — | US | disclosed |
| US-8178547-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-05-15 | — | — | US | disclosed |
| US-8158631-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-04-17 | — | — | US | disclosed |
| US-8158631-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-04-17 | — | — | US | disclosed |
| US-20120059176-A1 | ANTI-INFLAMMATORY MODALITIES | MARSHALL EDWARDS, INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-20120059176-A1 | ANTI-INFLAMMATORY MODALITIES | MARSHALL EDWARDS, INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-20120059176-A1 | ANTI-INFLAMMATORY MODALITIES | MARSHALL EDWARDS, INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| WO-2011073114-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-23 | — | — | WO | disclosed |
| CN-101203219-B | Anti-inflammatory modalities | NOVOGEN RES PTY LTD | 2011-06-15 | — | — | CN | disclosed |
| US-20110123490-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | ROCHE PALO ALTO LLC (US) | 2011-05-26 | — | — | US | disclosed |
| US-20110123490-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | ROCHE PALO ALTO LLC (US) | 2011-05-26 | — | — | US | disclosed |
| US-20110123490-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | ROCHE PALO ALTO LLC (US) | 2011-05-26 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20100330032-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | CHIN ELBERT | 2010-12-30 | — | — | US | disclosed |
| US-20100330032-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | CHIN ELBERT | 2010-12-30 | — | — | US | disclosed |
| CN-1847296-B | Polyolefin resin composition | SUMITOMO CHEMICAL CO | 2010-12-01 | — | — | CN | disclosed |
| US-20100179138-A1 | Isozazole Compounds As Inhibitors Of Heat Shock Proteins | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
| WO-2010072598-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-07-01 | — | — | WO | disclosed |
| US-20100158860-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | STEINER SANDRA | 2010-06-24 | — | — | US | disclosed |
| US-20100158860-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | STEINER SANDRA | 2010-06-24 | — | — | US | disclosed |
| US-7705027-B2 | Isoxazole compounds as inhibitors of heat shock proteins | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2010-04-27 | — | — | US | disclosed |
| US-7605221-B2 | Aromatic polycarbonateester block or random copolymer and polysiloxane blend primarily containing isophthalic and terephthalic acids, resorcinol and dimethylsilanediol monomers; films are radiation transparent; improved ductility at lower temperatures; aircraft components | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-10-20 | — | — | US | disclosed |
| CN-100526983-C | Composition for forming antireflection film | NISSAN CHEMICAL IND LTD (JP) | 2009-08-12 | — | — | CN | disclosed |
| CN-101506267-A | Weather-and heat-stable polymers with improved flow components | SABIC INNOVATIVE PLASTICS IP (NL) | 2009-08-12 | — | — | CN | disclosed |
| US-20090192152-A1 | Novel Antigiardial Agents and Methods of Use Thereof | UNIVERSITY OF MISSISSIPPI | 2009-07-30 | — | — | US | disclosed |
| US-20090192152-A1 | Novel Antigiardial Agents and Methods of Use Thereof | UNIVERSITY OF MISSISSIPPI | 2009-07-30 | — | — | US | disclosed |
| US-20090131513-A1 | ANTI-INFLAMMATORY MODALITIES | NOVOGEN RESEARCH PTY LTD. (AU) | 2009-05-21 | — | — | US | disclosed |
| US-20090131513-A1 | ANTI-INFLAMMATORY MODALITIES | NOVOGEN RESEARCH PTY LTD. (AU) | 2009-05-21 | — | — | US | disclosed |
| US-20090131513-A1 | ANTI-INFLAMMATORY MODALITIES | NOVOGEN RESEARCH PTY LTD. (AU) | 2009-05-21 | — | — | US | disclosed |
| EP-2032624-A1 | WEATHERABLE, THERMOSTABLE POLYMERS HAVING IMPROVED FLOW COMPOSITION | Sabic Innovative Plastics IP B.V. (NL) | 2009-03-11 | — | — | EP | disclosed |
| US-7468445-B2 | Antigiardial agents and use thereof | UNIVERSITY OF MISSISSIPPI (US) | 2008-12-23 | — | — | US | disclosed |
| US-7468445-B2 | Antigiardial agents and use thereof | UNIVERSITY OF MISSISSIPPI (US) | 2008-12-23 | — | — | US | disclosed |
| EP-1991552-A2 | PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES | Epoch Biosciences, Inc. (US) | 2008-11-19 | — | — | EP | disclosed |
| CN-101279915-A | Substituted phenol and application thereof as receptor TR3 excitant | UNIV XIAMEN (CN) | 2008-10-08 | — | — | CN | disclosed |
| CN-101203219-A | Anti-inflammatory modalities | NOVOGEN RES PTY LTD (AU) | 2008-06-18 | — | — | CN | disclosed |
| WO-2008002757-A1 | WEATHERABLE, THERMOSTABLE POLYMERS HAVING IMPROVED FLOW COMPOSITION | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-01-03 | — | — | WO | disclosed |
| EP-1861090-A1 | ANTI-INFLAMMATORY MODALITIES | Novogen Research Pty. Ltd. (AU) | 2007-12-05 | — | — | EP | disclosed |
| EP-1456180-B1 | 3-(2,4)DIHYDROXYPHENYL-4-PHENYLPYRAZOLES AND THEIR MEDICAL USE | VERNALIS CAMBRIDGE LTD (GB) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007098182-A2 | PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES, INC. (US) | 2007-08-30 | — | — | WO | disclosed |
| US-7247734-B2 | 3,4-diarylpyrazoles and their use in the therapy of cancer | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2007-07-24 | — | — | US | disclosed |
| US-20070027271-A1 | WEATHERABLE, THERMOSTABLE POLYMERS HAVING IMPROVED FLOW COMPOSITION | GENERAL ELECTRIC COMPANY (US) | 2007-02-01 | — | — | US | disclosed |
| US-20060241106-A1 | Isoxazole compounds as inhibitors of heat shock proteins | VERNALIS DEVELOPMENT LIMITED (GB) | 2006-10-26 | — | — | US | disclosed |
| WO-2006108212-A1 | ANTI-INFLAMMATORY MODALITIES | NOVOGEN RESEARCH PTY LTD (AU) | 2006-10-19 | — | — | WO | disclosed |
| CN-1847296-A | Polyolefin resin composition | SUMITOMO CHEMICAL CO (JP) | 2006-10-18 | — | — | CN | disclosed |
| EP-1611112-A1 | ISOXAZOLE COMPOUNDS AS INHIBITORS OF HEAT SHOCK PROTEINS | Vernalis (Cambridge) Limited (GB) | 2006-01-04 | — | — | EP | disclosed |
| US-20050222230-A1 | 3,4-diarylpyrazoles and their use in the therapy of cancer | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2005-10-06 | — | — | US | disclosed |
| CN-1636166-A | Composition for forming anti-reflective coating | NISSAN CHEMICAL IND LTD (JP) | 2005-07-06 | — | — | CN | disclosed |
| EP-1456180-A1 | 3,4-DIARYLPYRAZOLES AND THEIR USE IN THE THERAPY OF CANCER | Vernalis (Oxford) Ltd (GB) | 2004-09-15 | — | — | EP | disclosed |
| WO-2004073612-A2 | ESTROGEN RECEPTOR MODULATORS | MERCK & CO. INC. (US) | 2004-09-02 | — | — | WO | disclosed |
| WO-2004072051-A1 | ISOXAZOLE COMPOUNDS AS INHIBITORS OF HEAT SHOCK PROTEINS | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2004-08-26 | — | — | WO | disclosed |
| CN-1157355-C | Novel ester compound and themrosetting resin composition using the same | ס�ѻ�ѧ��ҵ��ʽ���� | 2004-07-14 | — | — | CN | disclosed |
| CN-1155655-C | Arylester compound and its prep, epoxy resin composition using the compound and copper-coated laminated | ס�ѻ�ѧ��ҵ��ʽ���� | 2004-06-30 | — | — | CN | disclosed |
| EP-1189900-B1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2004-01-14 | — | — | EP | disclosed |
| WO-2003055860-A1 | 3,4-DIARYLPYRAZOLES AND THEIR USE IN THE THERAPY OF CANCER | VERNALIS (CAMBRIDGE) LIMITED (GB) | 2003-07-10 | — | — | WO | disclosed |
| EP-1082115-A4 | HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2002-10-24 | — | — | EP | disclosed |
| US-6469109-B2 | COPPER CLAD LAMINATES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-1189900-A4 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2002-07-31 | — | — | EP | disclosed |
| EP-1189900-A1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-03-27 | — | — | EP | disclosed |
| EP-0699670-B1 | Aryl ester compound, its production process, epoxy resin composition using said compound, and copper-clad laminate using the epoxy resin composition | SUMITOMO CHEMICAL CO (JP) | 2002-03-06 | — | — | EP | disclosed |
| US-20020010288-A1 | Copper clad laminates | UEDA YOUICHI (JP) | 2002-01-24 | — | — | US | disclosed |
| US-6270899-B1 | AS CURING AGENT FOR EPOXY RESIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-07 | — | — | US | disclosed |
| US-6214869-B1 | SLEEP DISORDERS | BRISTOL-MYERS SQUIBB | 2001-04-10 | — | — | US | disclosed |
| US-6211225-B1 | SLEEP DISORDERS AND CIRCADIAN RHYTHM DISORDERS | BRISTOL-MEYERS SQUIBB | 2001-04-03 | — | — | US | disclosed |
| EP-1082115-A1 | HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-03-14 | — | — | EP | disclosed |
| CN-1284520-A | Arylester compound and its prep, epoxy resin composition using the compound and copper-coated laminated | SUMITOMO CHEMICAL CO (JP) | 2001-02-21 | — | — | CN | disclosed |
| CN-1284521-A | Aromatic ester compound and its prep., expoxy resin composition using the same and coper-coated laminate | SUMITOMO CHEMICAL CO (JP) | 2001-02-21 | — | — | CN | disclosed |
| CN-1060771-C | Aryl ester compound, process for producing the same, epoxy resin composition using the same, and copper-clad laminate using the same | SUMITOMO CHEMICAL CO (JP) | 2001-01-17 | — | — | CN | disclosed |
| WO-2001002392-A1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| EP-0811619-B1 | Novel ester compound and thermosetting resin composition using the same | SUMITOMO CHEMICAL CO (JP) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999062515-A1 | HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-12-09 | — | — | WO | disclosed |
| US-5916683-A | Copper-clad laminate with prepreg of epoxy resin and aryl ester | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1999-06-29 | — | — | US | disclosed |
| US-5726257-A | Esterified resorcinol-carbonyl compound condensates and epoxy resins therewith | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1998-03-10 | — | — | US | disclosed |
| CN-1170710-A | Novel ester compound and themrosetting resin composition using the same | SUMITOMO CHEMICAL CO (JP) | 1998-01-21 | — | — | CN | disclosed |
| EP-0811619-A1 | Novel ester compound and thermosetting resin composition using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-12-10 | — | — | EP | disclosed |
| EP-0746540-A1 | PREPARATION OF 4,6-DIAMINORESORCINOL THROUGH A BISAZOARYLRESORCINOL INTERMEDIATE | THE DOW CHEMICAL COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |
| CN-1125218-A | Novel aryl ester compound, process for producing the same, epoxy resin composition using the same, and copper-clad laminate using the same | SUMITOMO CHEMICAL CO (JP) | 1996-06-26 | — | — | CN | disclosed |
| EP-0699670-A2 | Aryl ester compound, its production process, epoxy resin composition using said compound, and copper-clad laminate using the epoxy resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-03-06 | — | — | EP | disclosed |
| US-5453542-A | Preparation of 4,6-diaminoresorcinol through a bisazoarylresorcinol intermediate | THE DOW CHEMICAL COMPANY (US) | 1995-09-26 | — | — | US | disclosed |
| WO-1995023130-A1 | PREPARATION OF 4,6-DIAMINORESORCINOL THROUGH A BISAZOARYLRESORCINOL INTERMEDIATE | THE DOW CHEMICAL COMPANY (US) | 1995-08-31 | — | — | WO | disclosed |
| US-5371291-A | Blocking, halogenating, removal the blocking, concurrent nitrating and hydrogenating | THE DOW CHEMICAL COMPANY (US) | 1994-12-06 | — | — | US | disclosed |
| US-5105027-A | Condensation of phenol with acetone | RHONE-POULENC CHIMIE (FR) | 1992-04-14 | — | — | US | disclosed |
| EP-0146923-B1 | PREPARATION OF HALOGENATED PHENOLS | FIDIA S.p.A. (IT) | 1991-07-10 | — | — | EP | disclosed |
| US-4704469-A | Preparation of halogenated phenols | FIDIA S.P.A. (IT) | 1987-11-03 | — | — | US | disclosed |
| EP-0146923-A1 | Preparation of halogenated phenols | FIDIA S.p.A. (IT) | 1985-07-03 | — | — | EP | disclosed |
| US-4487934-A | Method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1984-12-11 | — | — | US | disclosed |
| US-4487975-A | Etherification of phenols | RHONE-POULENC INDUSTRIES (FR) | 1984-12-11 | — | — | US | disclosed |
| US-4452811-A | VASODILATORS | FIDIA S.P.A. (IT) | 1984-06-05 | — | — | US | disclosed |
| EP-0041682-B1 | A METHOD OF PREPARING POLY-SUBSTITUTED ACYLBENZENES | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1983-09-21 | — | — | EP | disclosed |
| US-4398018-A | Temperature stable thermotropic poly(ester carbonate) derived from t-butylhydroquinone | ALLIED CORPORATION (US) | 1983-08-09 | — | — | US | disclosed |
| EP-0013532-B1 | PROCESS FOR THE PREPARATION OF POLYGLYCIDYL ETHERS OF POLYPHENOLS | RHONE-POULENC CHIMIE DE BASE (FR) | 1982-10-27 | — | — | EP | disclosed |
| EP-0045478-A1 | A method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1982-02-10 | — | — | EP | disclosed |
| EP-0041682-A1 | A method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-12-16 | — | — | EP | disclosed |
| US-4304941-A | Method of preparing poly-substituted acylbenzenes | HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-12-08 | — | — | US | disclosed |
| US-4296039-A | REACTING 2-HALORESORCINOLS OR THEIR MONOETHERS WITH BETA-KETO ESTERS | FIDIA S.P.A. (IT) | 1981-10-20 | — | — | US | disclosed |
| EP-0001734-B1 | IMIDE GROUPS CONTAINING POLYMERS, PROCESSES FOR THEIR PREPARATION AND THEIR USES FOR MAKING VARIOUS OBJECTS | RHONE-POULENC INDUSTRIES (FR) | 1981-06-17 | — | — | EP | disclosed |
| EP-0013532-A1 | Process for the preparation of polyglycidyl ethers of polyphenols | RHONE-POULENC CHIMIE DE BASE (FR) | 1980-07-23 | — | — | EP | disclosed |
| US-4156663-A | 260/857 R | KANEBO, LTD. (JP) | 1979-05-29 | — | — | US | disclosed |
| EP-0001734-A2 | Imide groups containing polymers, processes for their preparation and their uses for making various objects | RHONE-POULENC INDUSTRIES (FR) | 1979-05-02 | — | — | EP | disclosed |
| US-4072658-A | FLAME RETARDANTS | KANEBO, LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
| US-4072658-A | FLAME RETARDANTS | KANEBO, LTD. (JA) | 1978-02-07 | — | — | US | disclosed |